Global Large Volume Parenteral (LVP) Competitive Landscape Professional Research Report 2025

Research Summary

Large Volume Parenteral (LVP) refers to sterile injectable solutions that are administered intravenously and have a volume exceeding 100 milliliters. These solutions are typically used for delivering fluids, electrolytes, nutrients, or medications directly into the bloodstream to treat various medical conditions. LVPs are crucial in healthcare settings where patients require substantial fluid replacement or when the oral route of administration is not feasible. The larger volume distinguishes LVPs from Small Volume Parenterals (SVPs), which have volumes of 100 milliliters or less. LVPs are prepared under strict aseptic conditions to ensure their sterility and safety for intravenous administration. Common examples of LVPs include saline solutions, dextrose solutions, and other intravenous fluids used in hospitals, clinics, and healthcare facilities to address dehydration, maintain electrolyte balance, or administer medications efficiently.

According to DIResearch's in-depth investigation and research, the global Large Volume Parenteral (LVP) market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Large Volume Parenteral (LVP) include Baxter Healthcare, Kelun Pharma, B. Braun, Fresenius, Teva Pharmaceutical Industries, Pfizer (Hospira), Ostuka Pharmaceutical, CR Double-Crane, Pisa, Huaren, Patheon, Beximco Pharma, Albert David, PSI Ltd, Ozon Pharmaceuticals, BAG Healthcare, BML Parenteral Drugs etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Large Volume Parenteral (LVP). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Large Volume Parenteral (LVP) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Large Volume Parenteral (LVP) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Large Volume Parenteral (LVP) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Large Volume Parenteral (LVP) Include:

Baxter Healthcare

Kelun Pharma

B. Braun

Fresenius

Teva Pharmaceutical Industries

Pfizer (Hospira)

Ostuka Pharmaceutical

CR Double-Crane

Pisa

Huaren

Patheon

Beximco Pharma

Albert David

PSI Ltd

Ozon Pharmaceuticals

BAG Healthcare

BML Parenteral Drugs

Large Volume Parenteral (LVP) Product Segment Include:

Soft Bag LVP

Plastic Bottle LVP

Glass Bottle LVP

Large Volume Parenteral (LVP) Product Application Include:

Basic Infusion

Therapeutic Infusion

Nutritious Infusion

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Large Volume Parenteral (LVP) Industry PESTEL Analysis

Chapter 3: Global Large Volume Parenteral (LVP) Industry Porter’s Five Forces Analysis

Chapter 4: Global Large Volume Parenteral (LVP) Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Large Volume Parenteral (LVP) Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Large Volume Parenteral (LVP) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Large Volume Parenteral (LVP) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Large Volume Parenteral (LVP) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Large Volume Parenteral (LVP) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Large Volume Parenteral (LVP) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Large Volume Parenteral (LVP) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Large Volume Parenteral (LVP) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources